Controlled release formulation
The present invention relates to a controlled release pharmaceutical composition comprising amounts ranging from about 0.1 to about 4.5% w/w, of one or more of rate controlling cellulosic ether polymers.
Ranbaxy Laboratories Limited
A
A61K
inventional
Manoj Rajeev S. Ashok
Kumar Raghuvanshi Rampal